Cubist Systematic Strategies, LLC Insulet Corp Call Options Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$180.69 - $239.01 $1.43 Million - $1.89 Million	-7,900 Reduced 58.09%	5,700 $1.33 Million
Q2 2024 Aug 14, 2024	SELL	$161.02 - $206.98 $2.54 Million - $3.27 Million	-15,800 Reduced 53.74%	13,600 $2.74 Million
Q1 2024 May 15, 2024	SELL	$163.6 - $209.11 $229,040 - $292,754	-1,400 Reduced 4.55%	29,400 $5.04 Million
Q4 2023 Feb 14, 2024	SELL	$127.77 - $221.42 $715,512 - $1.24 Million	-5,600 Reduced 15.38%	30,800 $6.68 Million
Q3 2023 Nov 14, 2023	BUY	$154.67 - $290.89 $5.24 Million - $9.86 Million	33,900 Added 1356.0%	36,400 $5.81 Million
Q2 2023 Aug 14, 2023	BUY	$272.48 - $330.23 $681,200 - $825,575	2,500 New	2,500 $720,000

685

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.